
Journal of Heterocyclic Chemistry p. 103 - 107 (2000)
Update date:2022-07-30
Topics:
Kim, Ho Sik
Kwag, Sam Tag
Choi, Kyung Ok
Okamoto, Yoshihisa
Kajiwara, Shinnosuke
Fujiwara, Noriko
Kurasawa, Yoshihisa
The reaction of 6-chloro-2-hydrazinoquinoxaline 4-oxide 1b with acetylacetone or benzoylacetone gave 6-chloro-2-(3,5-dimethylpyrazol-1- yl)quinoxaline 4-oxide 5a or 6-chloro-2-(3-methyl-5-phenylpyrazol-1- yl)quinoxaline 4-oxide 5b, respectively. Compound 5a or 5b was converted into the pyrrolo[1,5-a]quinoxaline 6a or 6b, triazolo[4,3-a]quinoxaline 9a or 9b, and tetrazolo[1,5-a]quinoxaline 10.
Contact:+86-515-88356562
Address:No.2, West Daqing Road, Yancheng, Jiangsu, China
Linyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
Hangzhou Share Chemical Co., Ltd(expird)
Contact:+86-57187093700
Address:Hang Xing Road
Shenzhen JYMed Technology Co.,Ltd.
website:http://www.jymedtech.com
Contact:+86-755-26612112
Address:1#8,9/F, Biomedicine innovation Industrial Park, No.14, Jinhui Road, Pingshan Sistrict, Shenzhen, China
Wuxi Pharma-Trading Import & Export Co.,Ltd.
Contact:+86-510-82304590 82716390
Address:Room 523,Youzu Alliance Building,No.88 Renmin Zhonglu,Wuxi,Jiangsu,China
Doi:10.1016/S0003-2670(00)88751-6
(1964)Doi:10.1016/0022-328X(89)85042-9
(1989)Doi:10.1021/jo00800a065
(1971)Doi:10.1021/jo00802a017
(1971)Doi:10.1007/s10947-006-0054-9
(2005)Doi:10.1039/c39950001993
(1995)